Home >> Signaling Pathways >> Immunology/Inflammation

Immunology/Inflammation(免疫及炎症)

The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.

Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].

BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].

Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.

Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].

 

References

[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.

[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.

[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.

[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.

[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.

[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.

[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.

[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.

Products for  Immunology/Inflammation

  1. Cat.No. 产品名称 Information
  2. GC66370 Zapalog Zapalog 是一种光可裂解的小分子异二聚体,可用于重复启动和瞬间终止两种靶蛋白之间的物理相互作用。 Zapalog 对用 FKBP 和 DHFR 结构域标记的任何两种蛋白质进行二聚化,直到暴露于光下导致其光解。
  3. GC66363 Randialic acid B Randialic acid B 是一种三萜化合物,是一种甲酰肽受体 1 (FPR1) 拮抗剂。Randialic acid B 阻断人中性粒细胞中的 FPR1 并在体内减轻银屑病样炎症。
  4. GC66356 Cusatuzumab Cusatuzumab 是一种人 αCD70 单克隆抗体。 Cusatuzumab 显示出增强抗体依赖性的细胞毒性。 Cusatuzumab 可减少白血病干细胞 (LSC) 并触发与骨髓分化和凋亡 apoptosis 相关的基因特征。Cusatuzumab 具有研究急性白血病 (AML) 的潜力。
  5. GC66354 Ezetimibe-d4-1

    SCH 58235-d4-1

    An internal standard for the quantification of ezetimibe
  6. GC66350 Tralokinumab Tralokinumab 是一种全人源 IgG4 单克隆抗体,可与单独的 IL-13 以高亲和力特异性结合,防止其与受体相互作用和随后的下游信号传导。Tralokinumab 可用于特应性皮炎 (AD) 的研究。
  7. GC66348 Sutimlimab Sutimlimab 是首创的补体蛋白成分 1,s 亚成分 (C1s)抑制剂,可用于冷凝集素综合征的研究。C1s 是一种丝氨酸蛋白酶,可切割 C4 和 C2 以形成 C3 转化酶。
  8. GC66347 Mepolizumab

    SB 240563

    Mepolizumab (SB 240563) 是一种人源化的单克隆抗体,可结合并中和白细胞介素 5 (IL-5),白细胞介素 5 (IL-5) 是参与嗜酸性粒细胞增殖、活化和存活的主要细胞因子。Mepolizumab 可用于嗜酸性肉芽肿伴多血管炎 (EGPA) 和重度嗜酸性哮喘的研究。
  9. GC66343 n-Butyl-β-D-fructofuranoside n-Butyl-β-D-fructofuranoside 可以从 kangaisan 中分离出来。n-Butyl-β-D-fructofuranoside 通过线粒体途径诱导细胞凋亡。n-Butyl-β-D-fructofuranoside 可用于癌症研究。
  10. GC66342 Satralizumab Satralizumab 是一种人源化单克隆抗体,是一种有效的白细胞介素 -6 (IL-6) 抑制剂。Satralizumab 可防止褐家鼠的 dTAA 形成和发展。Satralizumab 可用于视神经脊髓炎 (NMOSD) 和降胸主动脉动脉瘤 (dTAA) 的研究。
  11. GC66341 ODN 2088 ODN 2088 是一种有效的 TLR3,TLR7 和 TLR9 抑制剂。ODN 2088 没有细胞毒性。ODN 2088 抑制 IFN-α 和 IL-6 的释放。
  12. GC66339 ODN 2216 ODN 2216 是一种 TLR9 (toll 样受体 9) 配体或激动剂。ODN 2216 诱导大量的 IFN-α 和 IFN-β。ODN 2216 通过 pDC (浆细胞样 DC) 诱导 IFN-α,并通过 DC (树突状细胞)产生 IL-12 (p40)。ODN 2216 刺激外周血单核细胞 (PBMC) 产生 IFN-γ,这是间接的和由 IFN-α/β 介导的。ODN 2216 可以激活 NK 细胞,促进 IFN-γ 产生 TCR 触发的 CD4+ T 细胞。
  13. GC66334 (Rac)-PF-184 hydrate (Rac)-PF-184 hydrate 是一种有效的 inhibitory factor-κB kinase 2 (IKK-2) 抑制剂,IC50 值为 37 nM。(Rac)-PF-184 hydrate 具有抗炎作用。
  14. GC66331 Basiliximab

    CHI 621

    Basiliximab (CHI 621) 是一种重组嵌合鼠/人 IgG1 单克隆抗白细胞介素 2 受体 (interleukin-2 receptor) 抗体。Basiliximab 可用于肾移植研究。

  15. GC66328 Canakinumab

    Ilaris; ACZ 885

    Canakinumab (ACZ885) 是一种重组的人抗 IL-1β 单克隆抗体。Canakinumab 显示出对人类和绒猴 IL-1β 的 IC50 值为分别为 43.6 和 40.8 pM。Canakinumab 的作用模式是基于对 IL-1β 信号的中和,从而抑制与自身免疫性疾病相关的炎症。

  16. GC66054 Nrf2 activator-4 Nrf2 activator-4 (Compound 20a) 是一种高效的、具有口服活性的 Nrf2 激活剂,EC50 值为 0.63 µM。Nrf2 activator-4 抑制小神经胶质细胞中活性氧 (reactive oxygen species) 的产生。Nrf2 activator-4 在 scopolamine 诱导的小鼠模型中能有效地恢复学习和记忆损伤。
  17. GC66019 MLN120B dihydrochloride

    ML120B dihydrochloride

    An IKKβ inhibitor
  18. GC66008 STING agonist-7 STING agonist-7 是一种非核苷酸 STING 激动剂,选择性结合小鼠 STING 而不是人类 STING。STING agonist-7 穿透细胞膜较差。
  19. GC66004 K67 K67 特异性抑制 Keap1 和 S349磷酸化 p62 之间的相互作用。K67 抑制 p-p62 与 Keap1 的竞争性结合,通过恢复 Keap1 驱动的 Nrf2 泛素化降解,有效抑制高表达S351磷酸化 p62 的 HCC 细胞的增殖。
  20. GC65995 NOD2 antagonist 1

    NOD2 antagonist 1 (compound 32) 是一种有效且具有选择性的 NOD2 拮抗剂,IC50 为 5.23 μM。NOD2 antagonist 1 可在 THP-1 细胞中抑制 Muramyl dipeptide (MDP) 诱导的 IL-8 分泌,也在 PBMCs 细胞中抑制 MDP 诱导的 IL-6、IL-10 和 TNF-α 的水平升高。

  21. GC65930 Vitamin K3-d8

    维生素K3-d8

    Vitamin K3-d8 是 Vitamin K3 的氘代物。
  22. GC65924 Lipopolysaccharides

    脂多糖; LPS

    Lipopolysaccharides (LPS) 脂多糖是从革兰氏阴性菌外膜的外叶中提取的内毒素,由一个抗原 O- 特异性链、一个核心寡糖和脂质 A 构成。Lipopolysaccharides 是一种激活免疫系统的致病相关分子模式 (PAMP)。Lipopolysaccharides 激活免疫细胞的 TLR-4。 本产品来源于大肠杆菌 O55:B5。

  23. GC65915 TLR7/8 agonist 4 TLR7/8 agonist 4 (compound 41) 是一种有效的 TLR7/8 激动剂。TLR7/8 agonist 4 具有抗癌活性。
  24. GC52196 RGD Peptide

    H-甘氨酰-精氨酰-甘氨酰-天冬氨酰-天冬酰胺酰-脯氨酸-OH

    An inhibitor of integrin-ligand interactions
  25. GC52194 Dimethylamino Parthenolide

    DMAPT, LC-1

    An inhibitor of NF-κB
  26. GC52192 (S)-4'-nitro-Blebbistatin

    (-)-4'-nitro-Blebbistatin, p-nitro-Blebbistatin, para-nitro-Blebbistatin

    A more stable and less phototoxic form of (–)-blebbistatin
  27. GC52191 Deacetylanisomycin

    脱乙酰茴香霉素

    A derivative of anisomycin
  28. GC52190 Imidazole Ketone Erastin

    IKE

    Imidazole Ketone Erastin是一种有效的、代谢稳定的系统xc- 抑制剂和铁凋亡诱导剂。
  29. GC52188 MDL 800 An allosteric SIRT6 activator
  30. GC52185 (R,S)-Anatabine-d4

    RAC-盐酸安那他品-D4

    An internal standard for the quantification of (R,S)-anatabine
  31. GC52180 WAY-169916 A pathway-selective estrogen receptor ligand
  32. GC52174 Sulfadoxin-d4

    磺胺邻二甲氧嘧啶-D4,Sulphadoxine-d4

    An internal standard for the quantification of sulfadoxin
  33. GC52173 N-desmethyl-Doxylamine (succinate)

    氢催化杂质

    A metabolite of doxylamine
  34. GC52171 Clindamycin-d3 (hydrochloride)

    克林霉素-D3盐酸盐

    An internal standard for the quantification of clindamycin
  35. GC52165 Minosaminomycin

    MSM

    An antibiotic
  36. GC52164 Cu-ATSP

    copper-ATSP, CuII(atsp)

    A copper-containing bis(thiosemicarbazone) complex
  37. GC52154 Inflammasome Inhibitor 4b An inhibitor of NLRP3 inflammasome activation
  38. GC52153 CIN-16645

    LP-01

    An ionizable cationic amino lipid
  39. GC52145 Bradykinin (human, mouse, rat, bovine) (acetate)

    Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH, BK, RPPGFSPFR-OH

    An endogenous vasodilator
  40. GC52140 2-Methoxyhydroquinone

    2-甲氧基对苯二酚

    A phenolic compound
  41. GC52133 12-Tridecenoic Acid

    顺十三碳-12-烯酸

    A monounsaturated fatty acid
  42. GC52129 3-Amino-5-hydroxybenzoic Acid

    3-氨基-5-羟基苯甲酸

    A biosynthetic precursor to ansamycin antibiotics
  43. GC52128 AOD-9604 A synthetic lipolytic peptide
  44. GC52127 Pexiganan (acetate)

    培西加南

    An antimicrobial peptide
  45. GC20007 Ginsenoside CK

    20(S)-人参皂苷 C-K; Compound K

    Ginsenoside C-K, a bacterial metabolite of G-Rb1, exhibits anti-inflammatory effects by reducing iNOS and COX-2. Ginsenoside C-K exhibits an inhibition against the activity of CYP2C9 and CYP2A6 in human liver microsomes with IC50s of 32.0±3.6 μM and 63.6±4.2 μM, respectively.

  46. GC65610 (R)-5-Hydroxy-1,7-diphenyl-3-heptanone

    (R)-5-羟基-1,7-二苯基-3-庚酮

    (R)-5-Hydroxy-1,7-diphenyl-3-heptanone 是一种二芳基庚烷,存在于 Alpinia officinarum 中。(R)-5-Hydroxy-1,7-diphenyl-3-heptanone 通过激活 Nrf2/ARE 通路改善氧化应激和胰岛素抵抗。
  47. GC65588 GB1211

    GB1211

    GB1211 是一种具有口服活性的 galectin-3 (Gal-3) 抑制剂。
  48. GC65565 Cyproheptadine

    塞庚啶

    Cyproheptadine HCl(Periactin) is a hydrochloride salt form of cyproheptadine which is a histamine receptor antagonist.
  49. GC65556 Homomangiferin

    高芒果苷

    Homomangiferin 是一种芒果苷单甲醚。Homomangiferin 具有重要的药用特性,广泛用于缓解许多症状,如咳嗽和哮喘。
  50. GC65555 PROTAC FLT-3 degrader 1 PROTAC FLT-3 degrader 1 是基于 von Hippel-Lindau 的 FLT-3内部串联重复 (ITD) 降解剂 PROTAC,IC50为0.6 nM。抗增殖,诱导凋亡活性。
  51. GC65545 Cyclo(L-Phe-L-Pro)

    环(PHE-PRO)

    Cyclo(L-Phe-L-Pro) 可从 Pseudomonas fluorescens 和 Pseudomonas alcaligenes 无细胞培养上清液中分离得到,是一种抗真菌环状二肽。Cyclo(L-Phe-L-Pro)通过干扰视黄酸诱导基因-I (RIG-I) 的激活来抑制 IFN-β 产生。Cyclo(L-Phe-L-Pro) 还具有自由基清除活性,IC50 为 24 µM。

Items 851 to 900 of 4267 total

per page

Set Descending Direction